The expression of miR-100-5p was negatively correlated with tumor stage. miR-100-5p inhibits the translation of the corresponding mRNA of PD-L1/PD-L2, and decreases the protein of PD-L1/PD-L2, which is beneficial to the occurrence of tumor immunity. The gene discussed is CD274; the disease is neoplasm.